.png){kind=icon}
.png){kind=icon}
Return
Integrative Multiomics Analysis Identifies DKK3 as a Germline Susceptibility-Related Regulator of Risperidone Response and Metabolic Risk in Schizophrenia
.png){kind=icon}
OA
AI
X
J
Y
G
X
DOI：10.1155/humu/8434158.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Risperidone is a widely used second-generation antipsychotic for schizophrenia, known for its clinical efficacy but also for long-term metabolic side effects, including weight gain and glucose–lipid dysregulation. Although its therapeutic effects have been well characterized, the molecular basis linking its benefits and adverse metabolic outcomes remains poorly understood.
Keywords:
DKK3
germline mutation
metabolic dysregulation
risperidone
schizophrenia
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.7
Papers:
5.1K
Citations:
1.3W
Organization
Cited Papers